Healthcare Co.,Ltd. (SHA:603313)
China · Delayed Price · Currency is CNY 9.17
-0.81 (-8.12%)
At close: Feb 2, 2026
Healthcare Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 162.46 | -151.42 | 106.6 | 41.36 | -275.53 | 378.59 |
Depreciation & Amortization | 542.03 | 542.03 | 505.67 | 444.06 | 360.07 | 132.97 |
Other Amortization | 194.46 | 194.46 | 136.55 | 97.86 | 80.25 | 67.17 |
Loss (Gain) From Sale of Assets | -14.96 | -14.96 | -0.87 | 0.4 | 0.5 | -1.27 |
Asset Writedown & Restructuring Costs | 36.79 | 36.79 | 14.67 | 4.72 | 4.76 | 2.36 |
Loss (Gain) From Sale of Investments | 14.85 | 14.85 | 5.5 | -25.92 | -22.09 | -33.12 |
Provision & Write-off of Bad Debts | 374.45 | 374.45 | 81.73 | 39.55 | 80.96 | 34.74 |
Other Operating Activities | 34.59 | 148.24 | 233.75 | 92.19 | 270.66 | 230.65 |
Change in Accounts Receivable | -266.43 | -266.43 | -358.17 | -61.16 | -289.22 | -293.6 |
Change in Inventory | 65.49 | 65.49 | -10.89 | 191.97 | -594.39 | -628.25 |
Change in Accounts Payable | 101.81 | 101.81 | 256.95 | -231.99 | 529.57 | 738.84 |
Change in Other Net Operating Assets | - | - | - | - | -6.36 | 0.53 |
Operating Cash Flow | 1,164 | 963.9 | 916.62 | 565.39 | 67.92 | 582.53 |
Operating Cash Flow Growth | 89.42% | 5.16% | 62.12% | 732.41% | -88.34% | 348.81% |
Capital Expenditures | -339.89 | -379.33 | -414.53 | -631.07 | -539.44 | -915.43 |
Sale of Property, Plant & Equipment | 69.18 | 71.93 | 3.98 | 15.74 | 9.81 | 28.93 |
Cash Acquisitions | -6.75 | -4.03 | - | - | - | -356.29 |
Divestitures | -1.4 | - | 52.4 | 37.83 | - | - |
Investment in Securities | 20.34 | -70.25 | 2.25 | 18.03 | -16 | -85.78 |
Other Investing Activities | 92.82 | -13.41 | -7 | 10.48 | 24.61 | -2.19 |
Investing Cash Flow | -165.7 | -395.1 | -362.9 | -548.89 | -523.5 | -1,305 |
Short-Term Debt Issued | - | 200.7 | 431.6 | 795.03 | 40 | - |
Long-Term Debt Issued | - | 2,856 | 2,925 | 3,410 | 3,402 | 2,447 |
Total Debt Issued | 2,916 | 3,056 | 3,356 | 4,205 | 3,442 | 2,447 |
Long-Term Debt Repaid | - | -3,679 | -4,049 | -4,555 | -2,690 | -1,921 |
Net Debt Issued (Repaid) | -573.15 | -622.92 | -692.11 | -350.12 | 751.47 | 526.12 |
Issuance of Common Stock | - | - | 789.19 | - | - | 686.34 |
Repurchase of Common Stock | - | - | - | -6.94 | -6.44 | -0.67 |
Common Dividends Paid | -119.18 | -125.82 | -151.76 | -135.52 | -258.37 | -71.32 |
Other Financing Activities | -293.56 | -29.6 | -53.57 | -18.44 | -123.09 | -0.93 |
Financing Cash Flow | -985.89 | -778.35 | -108.25 | -511.02 | 363.57 | 1,140 |
Foreign Exchange Rate Adjustments | 89.34 | 24.54 | 91.76 | 170.2 | -192.26 | -160.75 |
Net Cash Flow | 101.88 | -185.01 | 537.23 | -324.32 | -284.27 | 256.15 |
Free Cash Flow | 824.25 | 584.57 | 502.1 | -65.68 | -471.52 | -332.91 |
Free Cash Flow Growth | 163.94% | 16.43% | - | - | - | - |
Free Cash Flow Margin | 9.08% | 6.92% | 6.30% | -0.82% | -5.79% | -5.10% |
Free Cash Flow Per Share | 1.45 | 1.04 | 1.04 | -0.14 | -0.97 | -0.74 |
Cash Income Tax Paid | 102.89 | 71.38 | 14.31 | -22.13 | -317.37 | -106.31 |
Levered Free Cash Flow | 680.63 | 741.35 | 424.38 | -355.18 | -414.99 | -395.15 |
Unlevered Free Cash Flow | 774.32 | 855.09 | 558.15 | -241.24 | -327.17 | -344.99 |
Change in Working Capital | -180.54 | -180.54 | -166.97 | -128.83 | -431.65 | -229.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.